Juvederm Volbella, a hyaluronic acid (HA) filler formulated with Allergan’s proprietary Vycross technology, has emerged as a standout option for subtle aesthetic enhancements. In 2022, it gained FDA approval for…
Sculptra, a poly-L-lactic acid (PLLA) injectable, has been a cornerstone in aesthetic medicine since its FDA approval for facial volume restoration in patients with lipoatrophy and for treating nasolabial folds….
In today’s aesthetic landscape, lip enhancement has evolved beyond the pursuit of volume alone. Patients increasingly seek subtle, natural-looking results that enhance their features while preserving individuality and movement. This…
Combination therapies play a vital role in aesthetic medicine, delivering comprehensive, non-surgical rejuvenation. Xeomin, a botulinum toxin type A, is notable for its “naked” formulation—free of complexing proteins—and FDA approval…